News - Merck KGaA, Vaccines


Current filters:

Merck KGaAVaccines

Popular Filters

News briefs from Threshold, Merck KGaA and GSK


US biotech firm Threshold Pharmaceuticals (Nasdaq: THLD) said yesterday that data from a Phase IIb trial…

BiotechnologyErbituxEuropeGlaxoSmithKlineMerck KGaAMerck SeronoOncologyPharmaceuticalRegulationResearchSynflorixTH-302Threshold PharmaceuticalsVaccines

Ark Therapeutics signs a letter of intent with Merck KGaA unit


UK-based Ark Therapeutics (LON: AKT) shares rose nearly 6.5% on the back of the good news that it has…

Ark TherapeuticsMerck KGaAMilliporePharmaceuticalProductionResearchVaccines

Back to top